ImageneBio (IMA) Shares Outstanding (2020 - 2025)
ImageneBio's (IMA) quarterly Shares Outstanding (Entity) came in at $8.5 million in Q3 2025, up 112.04% year-over-year from $4.0 million in Q3 2024, and up 112.04% quarter-over-quarter from $4.0 million in Q2 2025.
Analysis
ImageneBio (IMA) Shares Outstanding (2020 - 2025) Analysis & Trends
ImageneBio has disclosed Shares Outstanding (Entity) across 6 years of filings, most recently posting $8.5 million for Q3 2025.
- In Q3 2025, Shares Outstanding (Entity) rose 112.04% year-over-year to $8.5 million; the TTM figure through Sep 2025 stood at $8.5 million (up 112.04% YoY), while the FY2024 annual figure was $4.0 million, changed 0.0% from the prior year.
- Shares Outstanding (Entity) came in at $8.5 million for Q3 2025 at ImageneBio, up from $4.0 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $8.5 million in Q3 2025 to a low of $320842.0 in Q1 2021.
- Average Shares Outstanding (Entity) over 5 years is $3.6 million, with a median of $3.5 million recorded in 2023.
- Year-over-year, Shares Outstanding (Entity) soared 1249.4% in 2021 and changed 0.0% in 2024.
- Over 5 years, Shares Outstanding (Entity) stood at $2.3 million in 2021, then gained by 29.57% to $3.0 million in 2022, then jumped by 33.1% to $4.0 million in 2023, then changed by 0.0% to $4.0 million in 2024, then jumped by 112.04% to $8.5 million in 2025.
- Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $8.5 million in Q3 2025, $4.0 million in Q2 2025, and $4.0 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 540.00 Mn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 1.24 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 253.70 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 102.80 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 61.30 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 398.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 133.61 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 147.70 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 720.78 Mn |
| 10 | ImageneBio | 42.89 Mn | -92.46 Mn | - | 8.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 8.53 Mn |
| Sep 30, 2025 | 8.53 Mn |
| Jun 30, 2025 | 4.02 Mn |
| Mar 31, 2025 | 4.02 Mn |
| Dec 31, 2024 | 4.02 Mn |
| Sep 30, 2024 | 4.02 Mn |
| Jun 30, 2024 | 4.02 Mn |
| Mar 31, 2024 | 4.02 Mn |
| Dec 31, 2023 | 3.48 Mn |
| Sep 30, 2023 | 3.62 Mn |
| Jun 30, 2023 | 3.27 Mn |
| Mar 31, 2023 | 3.02 Mn |
| Dec 31, 2022 | 3.02 Mn |
| Sep 30, 2022 | 3.02 Mn |
| Jun 30, 2022 | 3.01 Mn |
| Mar 31, 2022 | 3.01 Mn |
| Dec 31, 2021 | 2.33 Mn |
| Sep 30, 2021 | 2.99 Mn |
| Jun 30, 2021 | 2.99 Mn |
| Mar 31, 2021 | 320,842.00 |